LONDON (Reuters) – Global regulators will shortly propose the first set of international rules for cryptoassets, including how existing norms could apply to the sector, a top regulator said on Tuesday. Cryptoasset companies are calling for a globally-coordinated approach to give certainty to the sector as they face a “fire hose” of differing approaches. The …
Global securities watchdog to propose rules for cryptoassets Read More »
By Foo Yun Chee BRUSSELS (Reuters) -UBS is expected to secure unconditional European Union antitrust approval for its planned takeover of struggling Credit Suisse, people familiar with the matter said on Tuesday, putting the Swiss bank closer to completing the deal. UBS agreed to buy Credit Suisse for 3 billion Swiss francs ($3.4 billion) in …
Exclusive-UBS set to gain EU nod for Credit Suisse deal, sources say Read More »
By Milana Vinn NEW YORK (Reuters) -Ed Wehle, a senior Barclays Plc technology banker, has resigned to join U.S. rival Citigroup Inc in New York, according to an internal memo seen by Reuters, adding to an exodus of top investment bankers from the London-based bank. An investment banking veteran of nearly three decades, Wehle will …
(Reuters) -Qatar’s Sheikh Jassim bin Hamad al-Thani made an improved final offer for Manchester United in an attempt to see off his main rival British petrochemicals billionaire Sir Jim Ratcliffe, The Times reported on Tuesday. Sheikh Jassim is offering to buy 100% of the club now for a price nearer to 5 billion pounds ($6.31 …
Qatar’s Sheikh Jassim makes improved final offer for Manchester United – The Times Read More »
(Reuters) – German investor sentiment fell more than expected in May, pointing to a worsening of the already unfavourable economic situation in the next six months. “As a result, the German economy could slip into a recession, albeit a mild one,” ZEW president Achim Wambach said. The ZEW economic research institute said on Tuesday that …
German investor morale plunges as recession fears rise Read More »
By Aby Jose Koilparambil (Reuters) -Land Securities would invest more in prime retail spaces in the near term, buoyed by positive outlook for that portfolio, its CEO said on Tuesday, after the British landlord’s year-end valuation of its properties trumped market view. Rising interest rates and deepening macro-economic worries have dampened a tentative recovery in …
UK’s Landsec adds retail to focus list after property valuation beats estimates Read More »
BRUSSELS (Reuters) – Euro zone economic growth was 0.1% quarter-on-quarter in the first three months of the year, the EU’s statistics agency confirmed on Tuesday, with rising employment and a sharp increase in exports that boosted the euro zone trade surplus. Eurostat also confirmed its earlier estimate that gross domestic product in the 20 countries …
Euro zone Q1 GDP growth confirmed at 0.1% q/q, Q1 exports jump Read More »
MUNICH (Reuters) – Former Audi boss Rupert Stadler accepted his role in committing fraud by negligence in the diesel emissions scandal, according to a statement made in German court on Tuesday, having agreed early in May to a deal which would get him a suspended sentence. The former CEO has been on trial for fraud …
Emissions scandal: Ex-Audi boss admits role in fraud by negligence in German court Read More »
BRUSSELS (Reuters) – The European Council on Tuesday said it had adopted the world’s first comprehensive set of rules for cryptoassets regulation (MiCa). MiCA, which was already approved by EU member states and the European parliament, requires crypto firms to be authorised by the EU to serve customers in the bloc, and to comply with …
EU Council adopts first legal framework to regulate crypto sector Read More »
(Reuters) -The U.S. Federal Trade Commission is expected to file a lawsuit as early as Tuesday to block Amgen Inc’s $27.8 billion deal to buy Horizon Therapeutics PLC, a person familiar with the matter told Reuters. Amgen struck a deal last year to buy Horizon to strengthen its rare diseases drugs portfolio. The company has …
FTC to block Amgen’s $27.8 billion deal for Horizon Therapeutics – source Read More »
